tirzepatide update Mission Family Medicine launches in-clinic program Circle - 🚨URGENT UPDATE: Compounded

These studies will assess both the risks and benefits of modulating glucagon action across different metabolic tissues

A.AgustiniB.Khler-ForsbergO.CusinC.KatzD.SylviaL

In contrast, longitudinal and retrospective research in older adults with type 2 diabetes have reported reductions in handgrip strength and accelerated sarcopenia with prolonged semaglutide use

KEY TAKEAWAYS Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes, with demonstrated superior efficacy in glycemic control and weight loss compared to existing treatments

Both medications can be expensive

What happens if a dose is missed during a research protocol